Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks

Canadian Journal of Cardiology

Volumn 15, Issue 1, 1999, Pages 57-64

  Cujec, Bibiana ^a,b   Mainra, Rahul ^a   Johnson, David H ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b Misericordia Family Medicine Centre   (Canada)

Author keywords

Cardioembolic stroke; Patent foramen ovale; Transesophageal echocardiography

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; TICLOPIDINE; WARFARIN;

ADOLESCENT; ADULT; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; FEMALE; HEART ATRIUM SEPTUM DEFECT; HUMAN; HYPERTENSION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NEUROLOGY; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK;

ADOLESCENT; ADULT; CEREBROVASCULAR DISORDERS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; INFORMED CONSENT; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; ODDS RATIO; RECURRENCE; RISK FACTORS;

EID: 0033001012     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Lechat PH, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-52.
2. Webster MWI, Smith HJ, Sharpe DN, Chancellor AM, Swift DL, Bass NM. Patent foramen ovale in young stroke patients. Lancet 1988;ii:11-2.
3. Hanna JP, Sun JP, Furlan AJ, Stewart WJ, Sila CA, Tan M. Patent foramen ovale and brain infarct. Echocardiographic predictors, recurrence, and prevention. Stroke 1994;25:782-6.
4. Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. The French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart J 1995;130:1083-8.
5. Bogousslavsky J, Garazl S, Jeanrenaud X, Aebischer N, Van Melle G. Stroke recurrence in patients with patent foramen ovale: The Lausanne Study. The Lausanne Stroke with Paradoxal Embolism Study Group. Neurology 1996;46:1301-5.
6. Homma S, DiTulllo MR, Sacco RL, Mihalatos D, Mandri GL, Mohr JP. Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke 1994;25:582-6.
7. Stone DA, Godard J, Correttl MC, et al. Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J 1996;131:158-61.
8. Wade DT, Hewer RL. Functional abilities after stroke: measurement, natural history and prognosis. J Neurol Neurosurg Psychiatr 1987;50:177-82.
9. Nendaz M, Sarasin FP, Bogousslavsky J. How to prevent stroke recurrence in patients with patent foramen ovale: Anticoagulants, antiaggregants, foramen closure, or nothing? Eur Neurol 1997;37:199-204.
10. Devuyst G, Bogousslavsky J, Ruchat P, et al. Prognosis after stroke followed by surgical closure of patent foramen ovale: a prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound. Neurology 1996;47:1162-6.
11. Gin KG, Huckell VF, Pollick C. Femoral vein delivery of contrast medium enhances transthoracic echocardiographic detection of patent foramen ovale. J Am Coll Cardiol 1993;22:1994-2000.
12. Gent M. The Canadian American Ticlopidine (CATS) study in thromboembolic stroke. The CATS investigators. Lancet 1989;i:1215-20.
13. Bridges ND, Hellensbrand W, Catson L, Filiano J, Newsburger JW, Lock JE.Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992;86:1902-8,